Image6_Advances in Alzheimer’s disease’s pharmacological treatment.JPEG

Image6_Advances in Alzheimer’s disease’s pharmacological treatment.JPEG

<p>Alzheimer’s disease (AD) is the most common type of dementia in the elderly. Several hypotheses emerged from AD pathophysiological mechanisms. However, no neuronal protective or regenerative drug is available nowadays. Researchers still work in drug development and are finding new molecular...

Full description

Saved in:
Bibliographic Details
Main Author: Carlos Elias Conti Filho (14506280) (author)
Other Authors: Lairane Bridi Loss (14506283) (author), Clairton Marcolongo-Pereira (1967056) (author), Joamyr Victor Rossoni Junior (14506286) (author), Rafael Mazioli Barcelos (14506289) (author), Orlando Chiarelli-Neto (662945) (author), Bruno Spalenza da Silva (14506292) (author), Roberta Passamani Ambrosio (14506295) (author), Fernanda Cristina de Abreu Quintela Castro (14506298) (author), Sarah Fernandes Teixeira (14506301) (author), Nathana Jamille Mezzomo (14506304) (author)
Published: 2023
Subjects:
Pharmacology
Basic Pharmacology
Clinical Pharmacology and Therapeutics
Clinical Pharmacy and Pharmacy Practice
Pharmaceutical Sciences
Pharmacogenomics
Toxicology (incl. Clinical Toxicology)
Pharmacology and Pharmaceutical Sciences not elsewhere classified
Alzheimer’s disease
molecular target
drug development
pharmacological treatment
new drugs
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items